CRMD - MCAP CO - CorMedix Inc.

Exclusive patents for Defencath and powerful lobbying protect CorMedix Inc. (CRMD) from competitors amid strict FDA oversight. The production of antibacterial agents relies on certified contractors, eliminating supply chain disruptions. This daily price chart illustrates a market capitalization of 0.60. The integration of the catheter solution into mandatory medical protocols for dialysis centers ensures a stable revenue stream.

Market capitalization, defined as the product of the current share price and the total number of outstanding securities, reflects the aggregate real-time market value of the business. By analyzing the issuer's current aggregate capitalization, an investor assesses the market potential of CorMedix Inc. (CRMD), where valuation stability is supported by the integration of its catheter-infection drug into mandatory medical dialysis protocols.